ION BEAM APPLICATIONS (IBAB.BR) Stock Fundamental Analysis
Europe - Euronext Brussels - EBR:IBAB - BE0003766806 - Common Stock
10.98 EUR
-0.2 (-1.79%)
IBAB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. While IBAB is still in line with the averages on profitability rating, there are concerns on its financial health. IBAB is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
IBAB had positive earnings in the past year.
IBAB had a positive operating cash flow in the past year.
Of the past 5 years IBAB 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: IBAB reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of IBAB (2.71%) is comparable to the rest of the industry.
With an excellent Return On Equity value of 14.29%, IBAB belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.
IBAB's Return On Invested Capital of 15.54% is amongst the best of the industry. IBAB outperforms 93.65% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IBAB is below the industry average of 9.33%.
The 3 year average ROIC (6.20%) for IBAB is below the current ROIC(15.54%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROIC | 15.54% |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.2%
ROIC(5y)6.71%
1.3 Margins
IBAB has a Profit Margin of 2.85%. This is comparable to the rest of the industry: IBAB outperforms 42.86% of its industry peers.
IBAB's Profit Margin has declined in the last couple of years.
The Operating Margin of IBAB (6.48%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of IBAB has grown nicely.
With a Gross Margin value of 31.21%, IBAB is not doing good in the industry: 82.54% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of IBAB has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% |
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
2. Health
2.1 Basic Checks
IBAB has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
IBAB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, IBAB has less shares outstanding
IBAB has a worse debt/assets ratio than last year.
2.2 Solvency
IBAB has an Altman-Z score of 1.62. This is a bad value and indicates that IBAB is not financially healthy and even has some risk of bankruptcy.
IBAB has a Altman-Z score of 1.62. This is in the lower half of the industry: IBAB underperforms 63.49% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that IBAB is not too dependend on debt financing.
IBAB has a better Debt to Equity ratio (0.23) than 68.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.62 |
ROIC/WACC2.17
WACC7.17%
2.3 Liquidity
A Current Ratio of 0.94 indicates that IBAB may have some problems paying its short term obligations.
IBAB's Current ratio of 0.94 is on the low side compared to the rest of the industry. IBAB is outperformed by 84.13% of its industry peers.
A Quick Ratio of 0.62 indicates that IBAB may have some problems paying its short term obligations.
IBAB has a Quick ratio of 0.62. This is amonst the worse of the industry: IBAB underperforms 84.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 112.86% over the past year.
Measured over the past 5 years, IBAB shows a small growth in Earnings Per Share. The EPS has been growing by 3.99% on average per year.
IBAB shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.96%.
IBAB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.01% yearly.
EPS 1Y (TTM)112.86%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%75.35%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.7%
3.2 Future
Based on estimates for the next years, IBAB will show a very strong growth in Earnings Per Share. The EPS will grow by 58.71% on average per year.
IBAB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.63% yearly.
EPS Next Y180.98%
EPS Next 2Y112.13%
EPS Next 3Y69.87%
EPS Next 5Y58.71%
Revenue Next Year21.21%
Revenue Next 2Y12.69%
Revenue Next 3Y9.84%
Revenue Next 5Y2.63%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
IBAB is valuated rather expensively with a Price/Earnings ratio of 19.26.
77.78% of the companies in the same industry are more expensive than IBAB, based on the Price/Earnings ratio.
IBAB is valuated rather cheaply when we compare the Price/Earnings ratio to 25.65, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.11 indicates a reasonable valuation of IBAB.
Based on the Price/Forward Earnings ratio, IBAB is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of IBAB to the average of the S&P500 Index (34.45), we can say IBAB is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.26 | ||
| Fwd PE | 10.11 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IBAB is valued cheaper than 87.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.75 |
4.3 Compensation for Growth
IBAB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IBAB's earnings are expected to grow with 69.87% in the coming years.
PEG (NY)0.11
PEG (5Y)4.83
EPS Next 2Y112.13%
EPS Next 3Y69.87%
5. Dividend
5.1 Amount
IBAB has a Yearly Dividend Yield of 1.59%. Purely for dividend investing, there may be better candidates out there.
IBAB's Dividend Yield is a higher than the industry average which is at 2.22.
IBAB's Dividend Yield is slightly below the S&P500 average, which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.59% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
8.05% of the earnings are spent on dividend by IBAB. This is a low number and sustainable payout ratio.
DP8.05%
EPS Next 2Y112.13%
EPS Next 3Y69.87%
EBR:IBAB (11/25/2025, 1:09:54 PM)
10.98
-0.2 (-1.79%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners26.17%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap332.47M
Revenue(TTM)596.63M
Net Income(TTM)17.00M
Analysts80
Price Target14.96 (36.25%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.59% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP8.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.95%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)3.5%
EPS NY rev (3m)-8.9%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.26 | ||
| Fwd PE | 10.11 | ||
| P/S | 0.56 | ||
| P/FCF | N/A | ||
| P/OCF | 119.42 | ||
| P/B | 2.79 | ||
| P/tB | 3.52 | ||
| EV/EBITDA | 7.75 |
EPS(TTM)0.57
EY5.19%
EPS(NY)1.09
Fwd EY9.89%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.09
OCFY0.84%
SpS19.7
BVpS3.93
TBVpS3.12
PEG (NY)0.11
PEG (5Y)4.83
Graham Number7.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROCE | 25.19% | ||
| ROIC | 15.54% | ||
| ROICexc | 16.45% | ||
| ROICexgc | 19.79% | ||
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% | ||
| FCFM | N/A |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.2%
ROIC(5y)6.71%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.19%
ROCE(5y)10.93%
ROICexgc growth 3YN/A
ROICexgc growth 5Y52.5%
ROICexc growth 3Y-88.2%
ROICexc growth 5Y50.32%
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
F-Score7
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.54 | ||
| Cap/Depr | 65.94% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 5.44% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 1.62 |
F-Score7
WACC7.17%
ROIC/WACC2.17
Cap/Depr(3y)79.57%
Cap/Depr(5y)64.6%
Cap/Sales(3y)2.05%
Cap/Sales(5y)1.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)112.86%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%75.35%
EPS Next Y180.98%
EPS Next 2Y112.13%
EPS Next 3Y69.87%
EPS Next 5Y58.71%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.7%
Revenue Next Year21.21%
Revenue Next 2Y12.69%
Revenue Next 3Y9.84%
Revenue Next 5Y2.63%
EBIT growth 1Y38.72%
EBIT growth 3Y27.16%
EBIT growth 5Y65.71%
EBIT Next Year213.8%
EBIT Next 3Y66.86%
EBIT Next 5Y52.9%
FCF growth 1Y90.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y105.87%
OCF growth 3YN/A
OCF growth 5YN/A
ION BEAM APPLICATIONS / IBAB.BR FAQ
Can you provide the ChartMill fundamental rating for ION BEAM APPLICATIONS?
ChartMill assigns a fundamental rating of 4 / 10 to IBAB.BR.
What is the valuation status for IBAB stock?
ChartMill assigns a valuation rating of 6 / 10 to ION BEAM APPLICATIONS (IBAB.BR). This can be considered as Fairly Valued.
How profitable is ION BEAM APPLICATIONS (IBAB.BR) stock?
ION BEAM APPLICATIONS (IBAB.BR) has a profitability rating of 5 / 10.
What is the valuation of ION BEAM APPLICATIONS based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ION BEAM APPLICATIONS (IBAB.BR) is 19.26 and the Price/Book (PB) ratio is 2.79.
What is the earnings growth outlook for ION BEAM APPLICATIONS?
The Earnings per Share (EPS) of ION BEAM APPLICATIONS (IBAB.BR) is expected to grow by 180.98% in the next year.